| 1 | 6160-02-7 | Coumarin | C19H19NO2 | 293.36 | | |
| 2 | 6160-07-2 | N-(3-iodophenyl)-3-phenyl-propanamide | C15H14INO | | | |
| 3 | 6160-08-3 | 4-Hydroxy-3,5-diiodobenzenesufonic Acid Dihydrate, Sodium Salt, >95% | C6H7I2NaO5S | 467.98 | | |
| 4 | 6160-10-7 | 4-HYDROXY-3,5-DIIODOBENZENESUFONIC ACID DIHYDRATE, SODIUM SALT, >95% | C6H7I2NaO6S | 483.97989 | 120°C | |
| 5 | 6160-12-9 | sparteine sulfate | C15H28N2O4S | 332.46 | 133-140°C(lit.) | |
| 6 | 6160-14-1 | Acetamide,N-[(1S,2R,3E)-2-(acetyloxy)-1-[(acetyloxy)methyl]-3-heptadecen-1-yl]- | C22H19BrN4O3S | 499.380 | | |
| 7 | 6160-27-6 | Streptamine, N,N-bis (aminoiminomethyl)-, sulfate (1:1) (salt) | C8H20N6O8S | 360.3448 | | |
| 8 | 6160-32-3 | streptomycin hydrochloride | C21H39N7O12.3ClH | 618.04 | | |
| 9 | 6160-34-5 | STRONTIUM FORMATE DIHYDRATE | C2H6O6Sr | 213.69 | | |
| 10 | 6160-36-7 | STRONTIUM OXALATE MONOHYDRATE | C2H2O5Sr | 193.65 | | |
| 11 | 6160-56-1 | 4-[(2-naphthalen-2-yloxyacetyl)amino]benzamide | C6H12O4 | 148.16 | | |
| 12 | 6160-65-2 | 1,1'-Thiocarbonyldiimidazole | C7H6N4S | 178.21 | 98-102°C(lit.) | decomposes |
| 13 | 6160-69-6 | Lithium,[(1E)-2-phenylethenyl]- | C8H7Li | 110.08218 | | |
| 14 | 6160-78-7 | 7-(β-D-galactopyranosyloxy)-4-methyl-2H-1-benzopyran-2-one | C16H18O8 | 338.31 | 258-263°C (dec.) | soluble |
| 15 | 6160-79-8 | 4-Methylumbelliferyl 2,3,4,6-Tetra-O-acetyl-β-D-galactopyranoside | C24H26O12 | 506.46 | | |
| 16 | 6160-80-1 | 4-methyl-2-oxo-2H-1-benzopyran-7-yl β-D-glucopyranosiduronic acid | C16H16O9 | 352.3 | 102 °C | slightly soluble |
| 17 | 6160-83-4 | Nsc170147 | C9H18O11S3 | 398.42762 | | |
| 18 | 6160-92-5 | Methyl 4-azido-2-O,3-O-bis(methylsulfonyl)-4-deoxy-α-D-xylopyranoside | C8H15N3O8S2 | 345.34 | | |
| 19 | 6160-93-6 | a-D-Galactopyranoside, methyl 4,6-diazido-4,6-dideoxy-,2,3-dimethanesulfonate | C9H16N6O8S2 | 400.38874 | | |
| 20 | 61600-13-3 | N-(4,4-Dicyano-1,3-butadienyl)acetoanilide | C14H11N3O | 237.26 | | |
| 21 | 61600-15-5 | [3-(dihexylamino)allylidene]malononitrile | C18H29N3 | 287.45 | | |
| 22 | 61600-32-6 | L-Methionine, N-[N-[N-(N-L-tyrosyl-D-leucyl)glycyl]-L-phenylalanyl]- (9CI) | C31H43N5O7S | 629.77 | | |
| 23 | 61600-33-7 | L-Methionine, N-[N-[N-(N-L-tyrosyl-D-phenylalanyl)glycyl]-L-phenylalanyl]- (9CI) | C34H41N5O7S | 663.78 | | |
| 24 | 61600-34-8 | L-Methionine, L-tyrosylglycylglycyl-D-phenylalanyl- (9CI) | C27H35N5O7S | 573.66 | | |
| 25 | 61600-67-7 | 15-keto Prostaglandin A1 | C20H30O4 | 334.45 | | |
| 26 | 61600-69-9 | Thiourea, N-(5-chloro-2,4-dimethoxyphenyl)-N'-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thien-2-yl)- | C18H18ClN3O2S2 | 407.94 | | |
| 27 | 61600-71-3 | AURORA 671 | C16H17NO4S | 319.38 | | |
| 28 | 61600-72-4 | ethyl 2-{[(3-chloroanilino)carbonyl]amino}-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate | C18H19ClN2O3S | 378.87306 | | |
| 29 | 61600-98-4 | N-CYCLOPROPYLMETHYLUREA | C5H10N2O | 114.15 | | |
| 30 | 61601-28-3 | 1H-Indene-2-butanoic acid, 2,3-dihydro-1-oxo-, ethyl ester | C15H18O3 | 246.3 | | |
| 31 | 61601-29-4 | 1H-Indene-2-butanoic acid, 2,3-dihydro-1-hydroxy-, ethyl ester, cis- (9CI) | C15H20O3 | 248.32 | | |
| 32 | 61601-35-2 | 4H-Fluoren-4-one, 1,2,3,4a,9,9a-hexahydro-, (4aR,9aR)-rel- | C13H14O | 186.25 | | |
| 33 | 61601-38-5 | 8-Hydroxyquinoline-7-sulfonic acid hydrate | | | | |
| 34 | 61601-52-3 | 9H-Carbazol-3-ol, 8-methyl- | C13H11NO | 197.23254 | | |
| 35 | 61601-53-4 | 9H-Carbazol-3-ol, 7-methyl- | C13H11NO | 197.23254 | | |
| 36 | 61601-54-5 | 9H-Carbazol-1-ol | C12H9NO | 183.21 | 164 °C | |
| 37 | 61601-55-6 | Decanoic acid,3-[[6-deoxy-2-O-[6-deoxy-2-O-(1-oxo-2-decenyl)-a-L-mannopyranosyl]-a-L-mannopyranosyl]oxy]-, 1-(carboxymethyl)octyl ester | C42H74O14 | 803.02856 | | |
| 38 | 61601-56-7 | cholylglycylhistamine | C31H50N4O5 | 558.75 | | |
| 39 | 61601-59-0 | 1-[4-(1-Adamantyl)-2-thiazolylazo]-2-naphthol | C23H23N3OS | 389.51 | | |
| 40 | 61601-78-3 | (R)-N'-Nitrosonornicotine | C9H11N3O | 177.20314 | | |
| 41 | 61601-94-3 | 1,1'-BI(2,3-NAPHTHODIOL) | C20H14O4 | 318.32 | | |
| 42 | 61601-98-7 | SOLVENT YELLOW 62 | C26H41F6N2O8P | 654.58 | | |
| 43 | 61602-31-1 | 4-Cycloocten-1-ol, 8-(phenylamino)-, (1R,8R)-rel- | C14H19NO | 217.31 | | |
| 44 | 61602-97-9 | 3H-1,2,4-Triazino[5,6-b]indole-3-thione, 2,4-dihydro-4-methyl- | C10H8N4S | 216.26 | >340 °C (decomp) | |
| 45 | 61602-99-1 | 4H-1,2,4-Triazino[5,6-b]indole, 4-methyl-3-(methylthio)- | C11H10N4S | 230.29 | | |
| 46 | 61603-25-6 | 1-CHLORO-3H-BENZO[F]CHROMENE-2-CARBALDEHYDE | C14H9ClO2 | 244.67 | | |
| 47 | 61603-68-7 | Propanethioic acid, 2-hydroxy-, S-methyl ester (9CI) | C4H8O2S | 120.17 | | |
| 48 | 61604-21-5 | biphenyl-2,5,2',5'-tetrayltetraamine | C12H14N4 | 214.27 | | |
| 49 | 61604-22-6 | 5.5'-diamino-2.2'-dioxy-diphenyl | C12H12N2O2 | 216.24 | | |
| 50 | 61604-24-8 | 4,5,6-Pyrimidinetriamine, 2-(4-morpholinyl)- | C8H14N6O | 210.24 | | |
| 51 | 61604-50-0 | Benzoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-, 2-aminoethyl ester | C17H27NO3 | 293.4 | | |
| 52 | 61604-54-4 | 6-benzyl-8-thiabicyclo[3.2.1]oct-6-ene 8,8-dioxide | C14H16O2S | 248.34064 | | |
| 53 | 61604-82-8 | 9,10-Anthracenedione, 1,8-diamino-4,5-dimethoxy- | C16H14N2O4 | 298.29 | | |
| 54 | 61604-83-9 | Cyclohexanone, 2-(acetyloxy)-3-phenyl-, (2R,3R)-rel- | C14H16O3 | 232.27 | | |
| 55 | 61605-05-8 | 2,4-Pentanedione, 3,3'-[3-(1-acetyl-2-oxopropylidene)-1-cyclopropene-1,2-diyl]bis- | C18H20O6 | 332.35 | | |
| 56 | 61605-45-6 | Benzene, 1-isocyanato-3-propyl- | C10H11NO | 161.2 | | |
| 57 | 61605-46-7 | 2-amino-1,5-dihydro-1-octyl-4H-imidazol-4-one | C11H21N3O | 211.3 | | |
| 58 | 61605-47-8 | 2-Amino-1,5-dihydro-1-methyl-5-benzyl-4H-imidazol-4-one | C11H13N3O | 203.24 | | |
| 59 | 61605-49-0 | Benzenesulfonamide, 4-methyl-N-[4,4,6-trimethyl-2-(methylthio)-1(4H)-pyrimidinyl]- | C15H21N3O2S2 | 339.48 | | |
| 60 | 61605-52-5 | Acetic acid, 2-[[1,4-dihydro-4,4,6-trimethyl-1-[(phenylsulfonyl)amino]-2-pyrimidinyl]thio]-, ethyl ester | C17H23N3O4S2 | 397.51 | | |
| 61 | 61605-58-1 | Benzenesulfonamide, N-(3,4-dihydro-4,4,6-trimethyl-2-thioxo-1(2H)-pyrimidinyl)-4-methyl- | C14H19N3O2S2 | 325.45 | | |
| 62 | 61605-64-9 | Acetic acid, 2-[[1-[acetyl[(4-methylphenyl)sulfonyl]amino]-1,4-dihydro-4,4,6-trimethyl-2-pyrimidinyl]thio]-, ethyl ester | C20H27N3O5S2 | 453.58 | | |
| 63 | 61605-69-4 | Benzenesulfonamide, N-(3,4-dihydro-4,5,6-trimethyl-2-thioxo-1(2H)-pyrimidinyl)- | C13H17N3O2S2 | 311.42 | | |
| 64 | 61606-60-8 | 7β-[[[(Z)-Hydroxyimino]phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]cepham-3-ene-4-carboxylic acid | C18H17N7O5S2 | 475.5 | | |
| 65 | 61606-97-1 | Quinoline, 2-methyl-4-phenoxy- | C16H13NO | 235.28052 | | |
| 66 | 61607-08-7 | Cefmenoxime Impurity 12 | C16H21N7O6S2 | 471.51 | | |
| 67 | 61607-12-3 | Acetamide, 2-[(4,5-dihydro-5-thioxo-1,3,4-thiadiazol-2-yl)thio]- | C4H5N3OS3 | 207.3 | | |
| 68 | 61607-29-2 | 3-[(4-CHLOROPHENYL)SULFANYL]DIHYDRO-2,5-FURANDIONE | C10H7ClO3S | 242.68 | | |
| 69 | 61607-66-7 | (6R-trans)-7-amino-3-[[[1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | C13H19N7O3S2 | 385.47 | >109°C (dec.) | |
| 70 | 61607-68-9 | 1-(2-Dimethylaminoethyl)-5-Mercapto-1,2,3,4-Tetrazole | C5H11N5S | 173.24 | 215°C (dec.)(lit.) | |
| 71 | 61607-77-0 | Thiopyrano[4,3-b][1,5]benzodiazepine, 11-hydrazinyl-1,3,4,11a-tetrahydro- | C12H14N4S | 246.33 | | |
| 72 | 61607-78-1 | Thiopyrano[3,4-c]-1,2,4-triazolo[4,3-a][1,5]benzodiazepine, 9,10,11,13-tetrahydro- | C13H12N4S | 256.33 | | |
| 73 | 61607-82-7 | COPPERBIS(DODECYLBENZENESULFONATE)BIS(ETHYLENEDIAMINE) | C40H74CuN4O6S2 | 834.71476 | | |
| 74 | 61607-83-8 | Copper(hydroxynonylphenyl)sulphonate | C30H46CuO8S2 | 662.35744 | | |
| 75 | 61608-94-4 | Ethanone, 1-[2-(phenylmethyl)phenyl]- | C15H14O | 210.27 | | |
| 76 | 61609-20-9 | Cyclohexanone, 2-(1,1-dimethylethoxy)-4-(1,1-dimethylethyl)-, trans- (9CI) | C14H26O2 | 226.35 | | |
| 77 | 61609-22-1 | Cyclohexanone, 4-(1,1-dimethylethyl)-2-phenoxy-, trans- (9CI) | C16H22O2 | 246.34 | | |
| 78 | 61609-35-6 | Benzeneacetic acid, a-amino-a-cyclopropyl-, monosodium salt | C11H12NNaO2 | 213.20825 | | |